Prima BioMed Ltd – Request for a trading halt
Pursuant to ASX Listing Rule 17.1, Prima BioMed Ltd (Company) requests an immediate trading halt be granted by ASX with respect to its ordinary shares (ASX: PRR) and quoted options (ASX: PRRO).
The trading halt is requested pending an announcement in relation to the Company's decision to extend clinical trials of its flagship product candidate CVac™ in additional cancer indications.
The Company anticipates making an announcement in relation to the above before the commencement of trading on Wednesday, 26 June 2013 and is not aware of any reason why the trading halt should not be granted.
Yours sincerely
Deanne Miller
General Counsel & Company Secretary
About Prima BioMed Prima BioMed
prr in trading halt, page-15
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 29.5¢ | $598.4K | 2.003M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 192353 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 126073 | 7 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |